A randomized, single‐blinded, vehicle‐controlled study of a topical active blend in the treatment of androgenetic alopecia

    July 2020 in “Dermatologic Therapy
    Alexander C. Katoulis, Aikaterini I. Liakou, Dimitra Koumaki, Efstratios Vakirlis, Andreas G Tsantes, Despina Mortaki, E. Bozi, D. Ioannides
    Image of study
    TLDR Redenyl lotion effectively promotes hair growth and improves quality of life for androgenetic alopecia patients.
    The study evaluated the effectiveness of a topical lotion called Redenyl in treating androgenetic alopecia (AGA). The lotion contains two patented formulas: Redensyl and Sepicontrol A5. The study was conducted as a randomized, single-blinded, vehicle-controlled study with 44 patients diagnosed with AGA. The results showed that Redenyl was effective in promoting hair growth and improving patients' quality of life, with no significant side effects. The study suggests that Redenyl may be a promising new treatment option for AGA.
    View this study on onlinelibrary.wiley.com →

    Cited in this study